Abstract Body

Background

Mpox is a significant emerging public health concern, with an increasing number of community transmission cases reported in the US. The virus spreads through close contact with infected individuals such as exposure during intercourse, often leading to the development of genital lesions. This pattern of transmission overlaps with a rise in sexually transmitted infections, further complicating diagnosis. At the Dallas County Health and Human Services, the syphilis positivity rate stands at 29%, based on samples collected from 2022-2023. Meanwhile, herpes remains a common STIs in the US. Given the overlap in lesion presentations among Mpox, syphilis, and herpes, a multiplex PCR assay could detect these infections simultaneously providing streamlined testing protocols, enabling more efficient response to public health needs while ensuring accurate, timely results. The developed MPCR addresses current and emergent diagnostic needs of the community where commercial testing options are currently unavailable.

Methods

The protocol was evaluated using the TaqPath™ BactoPure™ Microbial Detection Master Mix for its high specificity and sensitivity for microbial DNA detection, the CDC primers/probe sets for the Mpox and extraction control detection, and the primers/probe sets for HSV1/2, and Treponema pallidum detection previously reported by the DCHHS2. DNA was extracted from samples using the QIAamp DSP DNA Mini Kit from dry swabs. Over 50 blinded samples were tested, including dry swab archived Mpox and syphilis samples, then compared to current comparable laboratory tests.

Results

The protocol showed >90% efficiency with a LoD of 10 genome copies. Mpox samples demonstrated perfect agreement with prior results (κ = 1), were mostly associated with genital lesions, and detection was confirmed by NGS. HSV samples also showed strong agreement (κ = 0.94), while syphilis had lower concordance due to limitations of darkfield microscopy, though the assay detected T. pallidum even in RPR-negative cases.

Conclusions

The MPCR assay enables simultaneous detection of Mpox, herpes, and syphilis, improving efficiency and aiding diagnosis of atypical genital lesion cases. It reduces testing time and resources for public health labs and introduces a novel NAT-based method for direct detection of T. pallidum at lesion sites. Reflex tests are being developed for MPXV clade determination and syphilis confirmation. The assay is planned for CLIA and FDA validation for integration into the DCHHS SHC testing algorithm.